Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07502885 · ClinicalTrials.gov registry record
Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Recruiting
- Registry status
- 300
- Enrollment target
NCT07502885 is a clinical trial that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 300 participants.
The verdict
NCT07502885 is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
Study Summary
The goal of DEEPGAIT study is to determine how serious walking problems are for pediatric cancer patients who have had orthopedic surgery, how they change over time, and what can be done to help. Healthy participants without cancer will also be included in this study in order to better understand the difference in walking problems between the 2 groups. DEEPGAIT is a long term study that uses advanced tools-including 3D motion capture, muscle sensors, force plates, and wearable devices-to take a detailed look at how these patients move. Their results are compared to healthy children of the same age and sex. PRIMARY OBJECTIVES * Characterize gait deficits in pediatric cancer patients 1 year following orthopedic surgery for lower limb bone sarcoma, soft tissue sarcoma, or steroid-induced avascular necrosis. * Identify personal, disease, treatment and environment risk factors for gait deficits in pediatric cancer patients 1 year following orthopedic surgery for lower limb bone sarcoma, soft tissue sarcoma, or steroid-induced avascular necrosis. SECONDARY OBJECTIVES * Build a library of broadly representative normative reference values to generate age- and sex-matched z-scores to quantify frequency, severity and progression of gait deficits among pediatric cancer patients in relation to healthy controls. * Characterize the changes of gait parameters in pediatric cancer patients with or without gait deficits 1 year after orthopedic surgery for lower limb bone sarcoma, soft tissue sarcoma, or steroid-induced avascular necrosis, up to 5 years after surgery. * Identify personal, disease, treatment and environment risk factors for trajectories of gait deficits in pediatric cancer patients with or without gait deficits 1 year after orthopedic surgery for lower limb bone sarcoma, soft tissue sarcoma, or steroid-induced avascular necrosis, up to 5 years after surgery.
Interventions
- DIAGNOSTIC_TEST Lab based 3D Gait Assessment
- DEVICE Wearable Inertial Sensors (In Lab and Remote)
- OTHER Functional Testing & Patient Reported Outcomes
- OTHER Remote Wearable Sensor Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-06-16 |
| Est. Completion | 2032-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07502885
The ClinicalTrials.gov registry entry for NCT07502885 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Lab based 3D Gait Assessment is the first listed.
NCT07502885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07502885 about?
NCT07502885 is a clinical study titled "Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients". The goal of DEEPGAIT study is to determine how serious walking problems are for pediatric cancer patients who have had orthopedic surgery, how they change over time, and what can be done to help. Healthy participants without cancer will also be included in this study in order to better understand th...
What is the current status of trial NCT07502885?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2026-06-16. Estimated completion is 2032-01.
What interventions are being tested in trial NCT07502885?
The interventions under investigation include: Lab based 3D Gait Assessment (DIAGNOSTIC_TEST), Wearable Inertial Sensors (In Lab and Remote) (DEVICE), Functional Testing & Patient Reported Outcomes (OTHER), Remote Wearable Sensor Assessment (OTHER).
Who is sponsoring clinical trial NCT07502885?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.